These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 34081788)

  • 61. Vitiligo - a disease: A position paper on stigmatization, life quality impairment and psychosocial comorbidity.
    Böhm M; Sommer R; Gieler U; Staubach P; Zink A; Apfelbacher C; Peters EMJ
    J Dtsch Dermatol Ges; 2024 Oct; 22(10):1327-1335. PubMed ID: 39167551
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The mosaic of autoimmunity - Finally discussing in person. The 13
    Mahroum N; Elsalti A; Alwani A; Seida I; Alrais M; Seida R; Esirgun SN; Abali T; Kiyak Z; Zoubi M; Shoenfeld Y
    Autoimmun Rev; 2022 Oct; 21(10):103166. PubMed ID: 35932955
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Immunosuppressive and immunomodulatory therapies in dermatology and coronavirus disease 2019 (COVID-19).
    Mansouri P; Farshi S; Nikkhah N; Nobari NN; Chalangari R; Nilforoushzadeh MA
    Clin Dermatol; 2021; 39(3):517-520. PubMed ID: 34518013
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Post-COVID Syndrome in Adults-An Overview.
    Scharf RE; Anaya JM
    Viruses; 2023 Mar; 15(3):. PubMed ID: 36992384
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Risk for COVID-19 Infection in Patients With Vitiligo.
    Smith B; Shahsavari S; Oulee A; Engel P; Egeberg A; Wu JJ
    Cutis; 2024 Apr; 113(4):E30-E32. PubMed ID: 38820098
    [No Abstract]   [Full Text] [Related]  

  • 66. The Long-term Complications of Covid-19 Infection.
    Meagher T
    J Insur Med; 2024 Jul; 51(2):111-115. PubMed ID: 39265998
    [TBL] [Abstract][Full Text] [Related]  

  • 67. VIRdb 2.0: Interactive analysis of comorbidity conditions associated with vitiligo pathogenesis using co-expression network-based approach.
    Srivastava P; Talwar M; Yadav A; Choudhary A; Mohanty S; Bharti S; Narad P; Sengupta A
    F1000Res; 2020; 9():1055. PubMed ID: 33763205
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cigarette smoking is an independent risk factor for developing vitiligo on the hands.
    Enomoto Y; Kanayama Y; Ikumi K; Sakurai M; Yamamoto A; Morita A
    Photodermatol Photoimmunol Photomed; 2024 Jan; 40(1):. PubMed ID: 38288764
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A chilblain epidemic during the COVID-19 pandemic. A sign of natural resistance to SARS-CoV-2?
    Lipsker D
    Med Hypotheses; 2020 Nov; 144():109959. PubMed ID: 32534339
    [No Abstract]   [Full Text] [Related]  

  • 70. Prevalence and characteristics of systemic autoimmune disease-related autoantibodies in convalescent patients after SARS-CoV-2 infection.
    Rosales-Castillo A; Sabio JM
    Clin Exp Rheumatol; 2023 Sep; 41 Suppl 135(9):9-10. PubMed ID: 35238762
    [No Abstract]   [Full Text] [Related]  

  • 71. The risk for severe COVID 19 in patients with autoimmune and/or inflammatory diseases: First wave lessons.
    Druyan A; Lidar M; Brodavka M; Levy I; Barzilai A; Pavlotsky F
    Dermatol Ther; 2021 Jan; 34(1):e14627. PubMed ID: 33277764
    [TBL] [Abstract][Full Text] [Related]  

  • 72. SARS-CoV-2 infection does not seem to worsen the clinical course of patients with oral autoimmune disease.
    Arduino PG; Gambino A; Broccoletti R
    Oral Dis; 2022 Nov; 28 Suppl 2():2593-2594. PubMed ID: 34343387
    [No Abstract]   [Full Text] [Related]  

  • 73. Treatment recommendations for patients with vitiligo during COVID-19.
    Rodrigues M; Pandya AG; Hamzavi I; Ezzedine K; Bekkenk MW; Harris JE
    Australas J Dermatol; 2021 Aug; 62(3):e481-e482. PubMed ID: 34028796
    [No Abstract]   [Full Text] [Related]  

  • 74. The mechanism behind flaring/triggering of autoimmunity disorders associated with COVID-19.
    Redwan EM; Alghamdi MF; El-Aziz TMA; Adadi P; Aljabali AAA; Attrish D; Azad GK; Baetas-da-Cruz W; Barh D; Bazan NG; Brufsky AM; Chauhan G; Hassan SKS; Kandimalla R; Lal A; Lundstrom K; Mishra YK; Choudhury PP; Palù G; Panda PK; Pizzol D; Rezaei N; Serrano-Aroca Á; Sherchan SP; Seyran M; Takayama K; Tambuwala MM; Uhal BD; Uversky VN
    Autoimmun Rev; 2021 Oct; 20(10):102909. PubMed ID: 34274539
    [No Abstract]   [Full Text] [Related]  

  • 75. Sudden onset of vitiligo after COVID-19 vaccine.
    Ciccarese G; Drago F; Boldrin S; Pattaro M; Parodi A
    Dermatol Ther; 2022 Jan; 35(1):e15196. PubMed ID: 34751491
    [No Abstract]   [Full Text] [Related]  

  • 76. New-onset vitiligo after COVID-19 mRNA vaccination: A causal association?
    Nicolaidou E; Vavouli C; Koumprentziotis IA; Gerochristou M; Stratigos A
    J Eur Acad Dermatol Venereol; 2023 Jan; 37(1):e11-e12. PubMed ID: 35971993
    [No Abstract]   [Full Text] [Related]  

  • 77. Autoantibodies in Covid-19 - a model for viral induced autoimmunity.
    Berger J; Volc S
    J Eur Acad Dermatol Venereol; 2021 Sep; 35(9):e571-e573. PubMed ID: 34031932
    [No Abstract]   [Full Text] [Related]  

  • 78. Correspondence on 'Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis'.
    Yang H; Xu J; Shi L; Duan G; Wang Y
    Ann Rheum Dis; 2023 Apr; 82(4):e79. PubMed ID: 33452002
    [No Abstract]   [Full Text] [Related]  

  • 79. COVID-19 and autoimmune phenomena: Vitiligo after Astrazeneca vaccine.
    López Riquelme I; Fernández Ballesteros MD; Serrano Ordoñez A; Godoy Díaz DJ
    Dermatol Ther; 2022 Jul; 35(7):e15502. PubMed ID: 35393710
    [No Abstract]   [Full Text] [Related]  

  • 80. Vitiligo-like Lesions and COVID-19: Case Report and Review of Vaccination- and Infection-Associated Vitiligo.
    Macca L; Peterle L; Ceccarelli M; Ingrasciotta Y; Nunnari G; Guarneri C
    Vaccines (Basel); 2022 Sep; 10(10):. PubMed ID: 36298511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.